中国微创外科杂志
中國微創外科雜誌
중국미창외과잡지
Chinese Journal of Minimally Invasive Surgery
2015年
10期
897-900
,共4页
楚蔚昕%葛伟平%张萍%陈龙%刘艳生%杨志豪
楚蔚昕%葛偉平%張萍%陳龍%劉豔生%楊誌豪
초위흔%갈위평%장평%진룡%류염생%양지호
子宫腺肌病%腹腔镜%促性腺激素释放激素激动剂
子宮腺肌病%腹腔鏡%促性腺激素釋放激素激動劑
자궁선기병%복강경%촉성선격소석방격소격동제
Uterine adenomyosis%Laparoscopy%Gonadotropin-releasing hormone agonist
目的:探讨腹腔镜子宫腺肌病病灶切除术联合促性腺激素释放激素激动剂(GnRH-a)治疗子宫腺肌病的疗效。方法回顾性分析2009年1月~2013年5月我院79例行腹腔镜子宫腺肌病病灶切除术患者的临床资料,其中手术联合药物组(A 组)42例,术后第3天皮下注射亮丙瑞林6个疗程(28天一次),单纯手术组(B 组)37例,比较2组治疗后痛经、月经量、子宫体积的变化。结果2组治疗后痛经分级降低(F =342.967,P =0.000),月经量评分降低(F =135.743,P =0.000),子宫体积缩小(F =393.341,P =0.000)。与 B 组相比,A 组痛经分级和月经量评分降低明显(F =14.274,P =0.000,F =18.222, P =0.000),子宫体积明显缩小(F =30.692,P =0.000)。随访12~64个月,(30.3±10.3)月,A 和 B 组的有效率分别为81.0%(34/42)、62.2%(21/37)(log-rank χ2=4.915,P =0.027)。结论腹腔镜子宫腺肌病病灶切除联合 GnRH-a 治疗能更有效地控制患者的临床症状,减少复发。
目的:探討腹腔鏡子宮腺肌病病竈切除術聯閤促性腺激素釋放激素激動劑(GnRH-a)治療子宮腺肌病的療效。方法迴顧性分析2009年1月~2013年5月我院79例行腹腔鏡子宮腺肌病病竈切除術患者的臨床資料,其中手術聯閤藥物組(A 組)42例,術後第3天皮下註射亮丙瑞林6箇療程(28天一次),單純手術組(B 組)37例,比較2組治療後痛經、月經量、子宮體積的變化。結果2組治療後痛經分級降低(F =342.967,P =0.000),月經量評分降低(F =135.743,P =0.000),子宮體積縮小(F =393.341,P =0.000)。與 B 組相比,A 組痛經分級和月經量評分降低明顯(F =14.274,P =0.000,F =18.222, P =0.000),子宮體積明顯縮小(F =30.692,P =0.000)。隨訪12~64箇月,(30.3±10.3)月,A 和 B 組的有效率分彆為81.0%(34/42)、62.2%(21/37)(log-rank χ2=4.915,P =0.027)。結論腹腔鏡子宮腺肌病病竈切除聯閤 GnRH-a 治療能更有效地控製患者的臨床癥狀,減少複髮。
목적:탐토복강경자궁선기병병조절제술연합촉성선격소석방격소격동제(GnRH-a)치료자궁선기병적료효。방법회고성분석2009년1월~2013년5월아원79례행복강경자궁선기병병조절제술환자적림상자료,기중수술연합약물조(A 조)42례,술후제3천피하주사량병서림6개료정(28천일차),단순수술조(B 조)37례,비교2조치료후통경、월경량、자궁체적적변화。결과2조치료후통경분급강저(F =342.967,P =0.000),월경량평분강저(F =135.743,P =0.000),자궁체적축소(F =393.341,P =0.000)。여 B 조상비,A 조통경분급화월경량평분강저명현(F =14.274,P =0.000,F =18.222, P =0.000),자궁체적명현축소(F =30.692,P =0.000)。수방12~64개월,(30.3±10.3)월,A 화 B 조적유효솔분별위81.0%(34/42)、62.2%(21/37)(log-rank χ2=4.915,P =0.027)。결론복강경자궁선기병병조절제연합 GnRH-a 치료능경유효지공제환자적림상증상,감소복발。
Objective To discuss the effect of laparoscopic adenomyomectomy combined with gonadotropin-releasing hormone agonist (GnRH-a)administration in the treatment of uterine adenomyosis. Methods Clinical data of 79 patients with uterine adenomyosis from January 2009 to May 2013 were collected.The patients of group A (42 cases)were given triptorelin for 6 courses after laparoscopic adenomyomectomy,whereas the patients of group B (37 cases)underwent laparoscopic adenomyomectomy alone. The dysmenorrhea,the menstrual amount and the uterine volume were analyzed. Results After treatment,the dysmenorrhea grade, the menstrual volume score and the uterine volume of the two groups were all significantly decreased (F =342.967,P =0.000;F =135.743,P =0.000;F =393.341 ,P =0.000 ).The dysmenorrhea grade and menstrual volume score in the group A were statistically lower than those in the group B (F =14.274,P =0.000;F =18.222,P =0.000).The uterine volume in the group A was smaller than that in the group B (F =30.692,P =0.000).The effect rates of group A and group B during follow-up were 81 .0%(34 /42 ) and 62.2% (21 /37 ),respectively (χ2 =4.915,P =0.027 ). Conclusions Laparoscopic adenomyomectomy can effectively used for uterine adenomyosis.Combined with GnRH-a after adenomyomectomy,the method is more effective in controlling symptoms and reducing disease recurrence.